Merck & Co., Inc.

126.24 CHF-7.14 (-5.35%)

XSWX:MRK.USDMarket Closed

AI Report

ListedCHFHealthcareDrug Manufacturers - General73,000 employees

Company Profile

Legal NameMerck & Co., Inc.

CEOMr. Robert M. Davis J.D.

Headquarters126 East Lincoln Avenue

Phone908 740 4000

Websitehttps://www.merck.com

Employees (FTE)73,000

SectorHealthcare

IndustryDrug Manufacturers - General

Business Description

Merck & Co., Inc. is a global biopharmaceutical company focused on developing and delivering prescription medicines, vaccines, biologic therapies, and animal health products. Its human health portfolio centers on oncology, infectious diseases, immunology, cardiometabolic care, and hospital acute care, while its vaccines business serves prevention needs across multiple disease areas. The company also operates a dedicated Animal Health segment that provides medicines, vaccines, and health solutions for companion animals and livestock. Merck & Co., Inc. plays an important role in global healthcare through research, development, and commercialization of products used by patients, veterinarians, and healthcare providers worldwide. Headquartered in Rahway, New Jersey, Merck & Co., Inc. is known in the U.S. and Canada as Merck, and as MSD in many international markets.

Price Summary

52-Week Low126.24

52-Week High133.38

50-Day MA0.00

200-Day MA0.00

Dividends

Dividend Date2019-07-08